68 TW Alexander Dr. RTP, NC 27709
+1 (919)-403-6583
+1 (919)-433-0220

Shape Pharmaceutical Commercialization Strategies with Market Research and Competitive Intelligence

Market research is necessary to understand the complexities of certain sales arenas. Companies spend money on market research to help understand the diverse subgroups of patients, doctors, nurses, caregivers and payer organizations present in individual markets. This research reveals unmet needs that, if addressed, translate into clear market opportunities.Commercialization teams face tremendous challenges as they bring new pharmaceutical brands to market. Many of the decisions these individuals make ultimately determine a brand’s success or failure. With this great weight on their shoulders, pharmaceutical commercialization strategies teams invest a great deal on market research and competitive intelligence prior to brands’ launches.

The desire to understand such information leads to market research consuming the largest percentage of many companies’ pharmaceutical brand commercialization budgets as their developing products pass between Phase III and launch. As shown in the accompanying Figure, survey results from some of our latest research indicates that between Phase III and launch participating companies spend an average of 17 percent of their brands’ commercialization budgets on market research. Another 4 percent of these budgets are earmarked for competitive intelligence.

U.S. Brand Launch Spending Between Phase IIIA and Marketing Approval

How Commercialization Teams Allocate Resources Between Phase IIIA and Marketing Approval (click for detail)


Once brands launch, spending on decision support activities dwindles quickly as potential scenarios turn to real events and the need for this type of research decreases. During early commercialization efforts, however, interviewed executives emphasize the importance of understanding the markets for products when aiming to achieve a quick sales uptake. By focusing commercialization efforts on uncovered market opportunities, companies are able to hit the ground running once they receive FDA approval.

David Richardson
Senior Director of FMV Services

Global Pharmaceutical Launches cover
Global Pharmaceutical Launches – Marketing Team Staffing and Budgets
Oncology brand Commercialization cover
Oncology Brand Commercialization
European Pharmaceutical Marketing cover
European Pharmaceutical Marketing: Resources for Launching Successful Brands

Related Posts


[…] the year comes to a close, Cutting Edge Information is taking a look at the best and worst brand launches in the US over the past year. The line between a massively successful launch and a potentially […]

[…] will be funniest?  What will Betty White be doing?  One thing that looks to be certain is that pharma companies won’t be joining this year’s commercial […]

[…] activities equip brands with the same level of commercial value.  To reap the most benefit from early commercialization, companies need to develop a firm understanding of their products’ potential uses and target […]

Leave a reply